Repatha 140 MG/ML sureclickml
Ended Awarded
- Contract number
- SPE2DR26FCL7N
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,231
Award facts
- Contract value 100% obligated
- $1,231.45 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $1,231.45 to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors. The contract, issued on October 30, 2025, with an ultimate completion date of October 31, 2025, utilizes firm fixed pricing with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform fulfillment from its corporate office location. This delivery order is issued under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026 that enables supply of a comprehensive range of medications and medical supplies to support military healthcare programs worldwide.
Repatha is a prescription medication used for cholesterol management in patients with cardiovascular disease or genetic conditions. As a child contract under the larger DLA pharmaceutical IDC, this delivery order represents routine medical supply procurement supporting Defense Health Agency operations and other federal healthcare systems. AmerisourceBergen Drug Corp's extensive federal contracting history demonstrates its established capability as a critical vendor in the military medical supply chain, with a portfolio spanning multiple therapeutic domains including specialty medications, vaccines, and medical devices. The DLA's engagement with AmerisourceBergen reflects the agency's reliance on experienced pharmaceutical distributors to maintain consistent availability of essential medications across military healthcare networks.
Quick answers
Who was awarded contract SPE2DR26FCL7N?
SPE2DR26FCL7N was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 30, 2025.
How much is contract SPE2DR26FCL7N worth?
The government has obligated $1,231 on SPE2DR26FCL7N.
Is contract SPE2DR26FCL7N an order under another contract?
Yes. SPE2DR26FCL7N is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCL7N competed?
The extent of competition for SPE2DR26FCL7N was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award